Applied DNA Sciences Signs Enterprise-Wide Agreement With One of the Top Four U.S. Defense Contractors for SigNature DNA Mark...
October 15 2013 - 08:30AM
Marketwired
Applied DNA Sciences Signs Enterprise-Wide Agreement With One of
the Top Four U.S. Defense Contractors for SigNature DNA Marking
STONY BROOK, NY--(Marketwired - Oct 15, 2013) - Applied DNA
Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of
DNA-based anti-counterfeiting technology and product authentication
solutions, announced today it has signed a ten-year option
agreement with one of the top four U.S. defense contractors to
purchase SigNature DNA® marking technology. The international
aerospace and defense company currently intends to apply its unique
SigNature DNA mark on FSC 5962 microcircuits in support of US
Defense Logistics Agency acquisition requirement (DLAD)
52.211-9074.
As a global leader, this defense contractor or "Prime" provides
key defense systems to the Defense Logistics Agency, as well as a
wide variety of advanced systems to military services and other
government and private sector customers.
As one path to counterfeit risk mitigation, DLA has adopted DNA
marking -- a powerful preventative solution. Now, with the addition
of one of the top Primes, the entire semiconductor supply chain,
from the point of manufacture, to the inclusion in higher-level
assemblies, can be protected with the forensic security that only
SigNature DNA can offer.
This company is a high-tech leader and supports military
services such as: Navy, Army, Air Force, and the Missile Defense
Agency, as well as non-military end users such as NASA and the
Department of Homeland Security.
"I am proud to have this innovative team join our growing list
of companies working together to prevent counterfeit infiltration,"
stated Janice Meraglia, Vice President of Government and Military
Programs at Applied DNA Sciences. "Each thought leader that joins
this critical effort to secure the defense supply chain sends a
strong message: end users are taking matters into their own hands
to ensure they provide the war fighters with as much protection as
the war fighters provide to each and every one of us," continued
Janice.
Dr. James A. Hayward, CEO and President, Applied DNA Sciences
stated, "Each additional participant in the DNA marking program
brings with them their own excellence in technological innovation
and buoys the 'can do' spirit Applied DNA Sciences embodies. We
believe this leader can help expand our SigNature DNA technology
platform and elevate it to the next level. The risk of counterfeit
parts in the electronics supply chain is a threat we have always
taken seriously, and we will work diligently to support this Prime
and encourage them to flow SigNature DNA marking across their
entire enterprise and to pull the technology through their own
suppliers and subcontractors," commented Dr. Hayward.
"We are a biotechnology company selling security products,"
continued Dr. Hayward, "and it is important that our investors
appreciate that in some cases, we must protect the identity of our
customers and partners. That is true in this case."
About Applied DNA Sciences
APDN is a provider of botanical-DNA based security and
authentication solutions that can help protect products, brands and
intellectual property of companies, governments and consumers from
theft, counterfeiting, fraud and diversion. SigNature® DNA and
smartDNA, our principal anti-counterfeiting and product
authentication solutions that essentially cannot be copied, provide
a forensic chain of evidence and can be used to prevent crime.
The statements made by APDN may be forward-looking in nature.
Forward-looking statements describe APDN's future plans,
projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of APDN. Actual results could
differ materially from those projected due to our short operating
history, limited financial resources, limited market acceptance,
market competition and various other factors detailed from time to
time in APDN's SEC reports and filings, including our Annual Report
on Form 10-K, filed on December 20, 2012 and our subsequent
quarterly reports on Form 10-Q. APDN undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events.
MEDIA CONTACT: Mitchell Miller 646-543-3373 fax: 631-240-8900
INVESTOR CONTACT: Debbie Bailey 631-240-8817 fax: 631-240-8900 Web
site: http://www.adnas.com Twitter: @APDN, @APDNInvestor
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2023 to Mar 2024